Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2026-06-20 @ 5:05 PM
Study NCT ID:
NCT01218568
Status:
COMPLETED
Last Update Posted:
2013-04-04
First Post:
2010-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial
Sponsor:
Institute of Liver and Biliary Sciences, India
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatic Encephalopathy | View |
Keywords: